Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burdenRahel Schwotzer, B. Gerber, Christine Waibel et al.|Hematological Oncology|2019Cited by 34
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry studyB. Gerber, Guido Ghilardi, Thomas Pabst et al.|Bone Marrow Transplantation|2018Cited by 20